Phase II multicenter sequential study of docetaxel (T) and epirubicin (E) followed by docetaxel (T) and capecitabine (X) as first-line treatment of advanced or metastatic breast cancer (MBC).

被引：0
|
作者：
Ramos, M
Casal, J
Galán, A
Almanza, C
León, L
Amenedo, M
Gonzalez, A
Huidobro, G
Giner, V
机构：
[1] Ctr Oncol Galicia, La Coruna, Spain
[2] Hosp Meixoeiro, Vigo, Spain
[3] Hosp Sagunto, Valencia, Spain
[4] Clin Povisa, Vigo, Spain
[5] Hosp Clin Santiago, Santiago De Compostela, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：54S / 54S
页数：1
相关论文
共 50 条
  • [1] Biweekly docetaxel (T) and capecitabine (X) as first-line treatment of metastatic breast cancer (MBC).
    Adrover, E
    Mayordomo, JI
    Llorca, C
    Burillo, MA
    Sanz, J
    Madroñal, C
    Lorenzo, A
    Palombo, H
    Janartz, J
    Pujol, E
    Machengs, I
    Yubero, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S202 - S202
  • [2] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
  • [3] Capecitabine in association with epirubicin and docetaxel as a first line treatment in advanced breast cancer. A multicenter phase II study.
    Rosso, R
    Del Mastro, L
    Durando, A
    Garrone, O
    Cherubini, R
    Scotto, T
    Genta, F
    Occelli, M
    Bellino, R
    Bighin, C
    Catzeddu, T
    Stevani, I
    Baldini, A
    Lambiase, A
    Venturini, M
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 270 - 270
  • [4] A phase II study of docetaxel (T) and capecitabine W combination chemotherapy as first-line chemotherapy for patients (pts) with metastatic breast cancer (MBC).
    Lim, HS
    Lee, HG
    Chun, JH
    Lee, JJ
    Lee, JS
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 100S - 100S
  • [5] Low dose sequential docetaxel-capecitabine chemotherapy as first-line treatment of metastatic breast cancer (mbc)
    Hafeez, M.
    Shaharyar, A.
    Masood, A. I.
    Zikria, M.
    Usman, A.
    Shabbir, K.
    Nadeem, Z.
    Tahir, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer
    Vici, P
    Foggi, P
    Colucci, G
    Capomolla, E
    Brandi, M
    Giotta, F
    Gebbia, N
    Di Lauro, L
    Valerio, MR
    Paoletti, G
    Belli, F
    Pizza, C
    Giannarelli, D
    Lopez, M
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1309 - 1314
  • [7] Vinorelbine (V) plus docetaxel (D) followed by Capecitabine (C) as first-line treatment of metastatic breast cancer (MBC)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 168 - 169
  • [8] Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II study
    Morales, S
    Lorenzo, A
    Ramos, M
    Ballesteros, P
    Méndez, M
    Almanza, C
    Moreno-Nogueira, J
    Casal, J
    Castellanos, J
    Lizón, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S68 - S68
  • [9] Phase II study of the combination of docetaxel, capecitabine and carboplatinum as first line therapy in metastatic breast cancer (MBC)
    Mokaddem, Walid
    Kattan, Joseph
    Chahine, Georges
    Nasr, Fadi
    Farhat, Fadi
    Tueni, Elias
    Dagher, Joya
    Younes, Fariha
    Ghosen, Marwan
    ANNALS OF ONCOLOGY, 2004, 15 : 45 - 46
  • [10] Sequential treatment with doxorubicin and docetaxel as first-line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II GEICAM study
    Alba, E
    Antón, A
    Ribelles, N
    Pérez-Carrión, R
    López-Vega, J
    Llanos, M
    Pelegri, A
    Florián, J
    Menéndez, M
    Godés, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S66
12345